[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
May 9, 2007

Influence or Education?

JAMA. 2007;297(18):1970. doi:10.1001/jama.297.18.1970-b

Manufacturers of pharmaceuticals, medical devices, and other health products and related trade associations spent $182 million on federal lobbying from January 2005 through June 2006, according to a report issued April 2.

The report, by the Center for Public Integrity, said much of the money was spent on lobbying that targets issues such as patent protection, restrictions on imports of lower-priced Canadian drugs, and the Medicare Prescription Drug Improvement and Modernization Act (which guarantees Medicare-eligible patients a prescription drug benefit while barring the federal government from negotiating drug prices). The Center for Public Integrity is a nonpartisan group based in Washington, DC, that does investigative reporting and research on public policy issues.

First Page Preview View Large
First page PDF preview
First page PDF preview
×